XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares and Additional Paid in Capital
Treasury Stock
Retained Earnings
Accumulated  Other Comprehensive Income
Non-Controlling Interests
Beginning balance (in shares) at Jun. 30, 2021   271,541,000        
Beginning balance (in shares) at Jun. 30, 2021     (1,568,000)      
Beginning balance at Jun. 30, 2021 $ 4,099,453 $ 1,947,764 $ (69,386) $ 2,153,326 $ 66,238 $ 1,511
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Under employee stock option plans (in shares)   905,000        
Under employee stock option plans 31,128 $ 31,128        
Under employee stock purchase plans (in shares)   595,000        
Under employee stock purchase plans 24,913 $ 24,913        
Share-based compensation $ 45,091 45,091        
Purchase of treasury stock (in shares) (1,700,000)   (1,700,000)      
Purchase of treasury stock $ (75,660)   $ (75,660)      
Issuance of treasury stock (in shares) 491,244   492,000      
Issuance of treasury stock $ 0 $ (21,013) $ 21,013      
Repurchase of Common Shares (in shares)   (2,810,000)        
Repurchase of Common Shares (136,117) $ (17,879)   (118,238)    
Dividends declared (178,613)     (178,613)    
Other comprehensive income (loss) - net (48,972)       (48,972)  
Distribution to non-controlling interest (396) $ 142       (538)
Net income for the period 295,024     294,894   130
Ending balance (in shares) at Mar. 31, 2022   270,231,000        
Ending balance (in shares) at Mar. 31, 2022     (2,776,000)      
Ending balance at Mar. 31, 2022 4,055,851 $ 2,010,146 $ (124,033) 2,151,369 17,266 1,103
Beginning balance (in shares) at Dec. 31, 2021   271,006,000        
Beginning balance (in shares) at Dec. 31, 2021     (1,476,000)      
Beginning balance at Dec. 31, 2021 4,129,825 $ 1,990,913 $ (67,966) 2,174,467 31,349 1,062
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Under employee stock option plans (in shares)   53,000        
Under employee stock option plans 1,863 $ 1,863        
Under employee stock purchase plans (in shares)   172,000        
Under employee stock purchase plans 7,003 $ 7,003        
Share-based compensation $ 16,748 $ 16,748        
Purchase of treasury stock (in shares) (1,300,000)   (1,300,000)      
Purchase of treasury stock $ (56,067)   $ (56,067)      
Issuance of treasury stock (in shares) 0          
Repurchase of Common Shares (in shares)   (1,000,000)        
Repurchase of Common Shares $ (45,083) $ (6,381)   (38,702)    
Dividends declared (59,077)     (59,077)    
Other comprehensive income (loss) - net (14,083)       (14,083)  
Net income for the period 74,722     74,681   41
Ending balance (in shares) at Mar. 31, 2022   270,231,000        
Ending balance (in shares) at Mar. 31, 2022     (2,776,000)      
Ending balance at Mar. 31, 2022 $ 4,055,851 $ 2,010,146 $ (124,033) 2,151,369 17,266 1,103
Beginning balance (in shares) at Jun. 30, 2022 269,522,639 269,523,000        
Beginning balance (in shares) at Jun. 30, 2022 3,706,420   (3,706,000)      
Beginning balance at Jun. 30, 2022 $ 4,032,260 $ 2,038,674 $ (159,966) 2,160,069 (7,659) 1,142
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Under employee stock option plans (in shares) 88,142 88,000        
Under employee stock option plans $ 2,473 $ 2,473        
Under employee stock purchase plans (in shares)   868,000        
Under employee stock purchase plans 22,997 $ 22,997        
Share-based compensation $ 88,535 88,535        
Purchase of treasury stock (in shares) 0          
Issuance of treasury stock (in shares) 490,026   490,000      
Issuance of treasury stock $ (1,070) $ (22,336) $ 21,266      
Dividends declared (195,844)     (195,844)    
Other comprehensive income (loss) - net (25,455)       (25,455)  
Net income for the period $ 199,251     199,113   138
Ending balance (in shares) at Mar. 31, 2023 270,479,181 270,479,000        
Ending balance (in shares) at Mar. 31, 2023 3,216,394   (3,216,000)      
Ending balance at Mar. 31, 2023 $ 4,123,147 $ 2,130,343 $ (138,700) 2,163,338 (33,114) 1,280
Beginning balance (in shares) at Dec. 31, 2022   270,235,000        
Beginning balance (in shares) at Dec. 31, 2022     (3,295,000)      
Beginning balance at Dec. 31, 2022 4,121,384 $ 2,092,079 $ (142,126) 2,171,236 (1,028) 1,223
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Under employee stock option plans (in shares)   16,000        
Under employee stock option plans 479 $ 479        
Under employee stock purchase plans (in shares)   228,000        
Under employee stock purchase plans 5,776 $ 5,776        
Share-based compensation $ 36,505 36,505        
Purchase of treasury stock (in shares) 0          
Issuance of treasury stock (in shares) 78,650   79,000      
Issuance of treasury stock $ (1,070) $ (4,496) $ 3,426      
Dividends declared (65,454)     (65,454)    
Other comprehensive income (loss) - net (32,086)       (32,086)  
Net income for the period $ 57,613     57,556   57
Ending balance (in shares) at Mar. 31, 2023 270,479,181 270,479,000        
Ending balance (in shares) at Mar. 31, 2023 3,216,394   (3,216,000)      
Ending balance at Mar. 31, 2023 $ 4,123,147 $ 2,130,343 $ (138,700) $ 2,163,338 $ (33,114) $ 1,280